Advertisement

Orenitram (treprostinil) Extended-release Tablets

Orenitram Integrated Campaign

PHILADELPHIA
2016
2016
Entrant Company
Calcium, Philadelphia
Medium
Integrated Campaign
Category
Integrated Campaign
Entry Type
Pharmaceutical: Direct to Professionals
Thumbnail for Orenitram Integrated Campaign
View Fullscreen

Items

Credits
Entrant CompanyCalcium, Philadelphia, Philadelphia
Agency NetworkCalcium, Philadelphia
Production CompanyNA, NA
ClientUnited Therapeutics Corporation, Durham
Founder, Chief Executive OfficerSteven Michaelson / Calcium, New York
Managing Partner, Chief Creative OfficerSteve Hamburg / Calcium, New York
Managing Partner, General ManagerGarth McCallum-Keeler / Calcium, San Francisco
SVP, Group Management DirectorMelissa Morrow / Calcium, Philadelphia
VP, Creative Director, ArtMick Rogers / Calcium, Philadelphia
Senior Art DirectorAshley Woodward / Calcium, Philadelphia
Account ExecutiveOliver Murphy / Calcium, Philadelphia
Creative Director/CopyChris Hatton / Calcium, Philadelphia

This 2016 Clio Health Bronze winning entry titled 'Orenitram Integrated Campaign' was entered for Orenitram (treprostinil) Extended-release Tablets by Calcium, Philadelphia, Philadelphia. The piece was submitted to the medium: Integrated Campaign within the entry type: Pharmaceutical: Direct to Professionals and the category: Integrated Campaign. It consists of 1 video and 1 image.

Advertisement
Advertisement